Matches in Nanopublications for { ?s ?p "treatment of ER-positive breast cancer with an activator of PKC, such as the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate, leads to rapid down-regulation of ER, destabilization of its mRNA, and phosphorylation of the ER protein, coincident with modulation of its function" ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- _6 value "treatment of ER-positive breast cancer with an activator of PKC, such as the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate, leads to rapid down-regulation of ER, destabilization of its mRNA, and phosphorylation of the ER protein, coincident with modulation of its function" provenance.
- _6 value "treatment of ER-positive breast cancer with an activator of PKC, such as the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate, leads to rapid down-regulation of ER, destabilization of its mRNA, and phosphorylation of the ER protein, coincident with modulation of its function" provenance.
- _5 value "treatment of ER-positive breast cancer with an activator of PKC, such as the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate, leads to rapid down-regulation of ER, destabilization of its mRNA, and phosphorylation of the ER protein, coincident with modulation of its function" provenance.